France
· Delayed Price · Currency is EUR Biophytis Statistics
Total Valuation
Biophytis has a market cap or net worth of EUR 3.46 million. The enterprise value is 10.94 million.
| Market Cap | 3.46M |
| Enterprise Value | 10.94M |
Important Dates
The last earnings date was Monday, April 14, 2025.
| Earnings Date | Apr 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Biophytis has 20.15 million shares outstanding. The number of shares has increased by 307.72% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 20.15M |
| Shares Change (YoY) | +307.72% |
| Shares Change (QoQ) | +84.55% |
| Owned by Insiders (%) | 0.24% |
| Owned by Institutions (%) | -0.04% |
| Float | 20.10M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | -0.54 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -0.73 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -1.01 |
Financial Position
The company has a current ratio of 0.41
| Current Ratio | 0.41 |
| Quick Ratio | 0.39 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.90 |
| Interest Coverage | -8.21 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -65.37% |
| Return on Invested Capital (ROIC) | -119.47% |
| Return on Capital Employed (ROCE) | 226.87% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -685,182 |
| Employee Count | 22 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -81.36% in the last 52 weeks. The beta is 1.92, so Biophytis's price volatility has been higher than the market average.
| Beta (5Y) | 1.92 |
| 52-Week Price Change | -81.36% |
| 50-Day Moving Average | 0.27 |
| 200-Day Moving Average | 0.37 |
| Relative Strength Index (RSI) | 28.35 |
| Average Volume (20 Days) | 342,728 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -12.20M |
| Pretax Income | -15.08M |
| Net Income | -15.07M |
| EBITDA | -11.80M |
| EBIT | -12.20M |
| Earnings Per Share (EPS) | -5.59 |
Balance Sheet
The company has 2.19 million in cash and 9.71 million in debt, giving a net cash position of -7.52 million or -0.37 per share.
| Cash & Cash Equivalents | 2.19M |
| Total Debt | 9.71M |
| Net Cash | -7.52M |
| Net Cash Per Share | -0.37 |
| Equity (Book Value) | -6.42M |
| Book Value Per Share | -1.22 |
| Working Capital | -8.35M |
Cash Flow
In the last 12 months, operating cash flow was -10.66 million and capital expenditures -139,000, giving a free cash flow of -10.80 million.
| Operating Cash Flow | -10.66M |
| Capital Expenditures | -139,000 |
| Free Cash Flow | -10.80M |
| FCF Per Share | -0.54 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Biophytis does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -307.72% |
| Shareholder Yield | -307.72% |
| Earnings Yield | -436.18% |
| FCF Yield | -312.60% |
Stock Splits
The last stock split was on May 3, 2024. It was a reverse split with a ratio of 0.0025.
| Last Split Date | May 3, 2024 |
| Split Type | Reverse |
| Split Ratio | 0.0025 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |